-
Roche's Genentech unit has filed a lawsuit in the US accusing Amgen of infringing a patent covering the cancer drug Avastin, Irish Examiner reported Monday.
-
Genentech said it has received a notice from the FDA that Amgen plans to launch its biosimilar, named Mvasi, in Ireland.
-
In seeking an injunction, Genentech argued that it will suffer substantial damage if Amgen is permitted to launch its therapy.
-
Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:To apply for becoming a contributor of En-CPhI.cn,
welcome to send your CV and sample works to us,
Email: Julia.Zhang@ubmsinoexpo.com.










(All Rights Reserved)